Metatypical basal cell carcinoma: a clinical review
2008

Metatypical Basal Cell Carcinoma: A Clinical Review

Sample size: 240 publication Evidence: moderate

Author Information

Author(s): Tarallo Mauro, Cigna Emanuele, Frati Riccardo, Delfino Sergio, Innocenzi Daniele, Fama Umberto, Corbianco Annamaria, Scuderi Nicolò

Primary Institution: Department of Dermatology and Plastic Surgery, University 'La Sapienza', Rome, Italy

Hypothesis

Is metatypical carcinoma a distinct entity of skin cancer that requires specific treatment and management?

Conclusion

Metatypical carcinoma requires careful differential diagnosis and specific treatment, as it is more aggressive than basal cell carcinoma.

Supporting Evidence

  • MTC affected more males than females (62.5% vs 37.5%).
  • The most affected site was the cervicofacial area (71.7%).
  • A recurrence occurred in 24 cases (10%), mainly in the head and neck area.

Takeaway

Metatypical carcinoma is a type of skin cancer that behaves between two other types and needs special attention when treated.

Methodology

The study retrospectively analyzed clinical records of 240 patients treated for metatypical skin cancer.

Limitations

The study is retrospective and may not represent all cases of metatypical carcinoma.

Participant Demographics

The study included 150 males and 90 females, with an average age of 70.5 years.

Digital Object Identifier (DOI)

10.1186/1756-9966-27-65

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication